Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

is a critical priority pathogen and causes life-threatening acute and biofilm-associated chronic infections. The choice of suitable treatment for complicated infections requires lengthy culturing for species identification from swabs or an invasive biopsy. To date, no fast, pathogen-specific diagnostic tools for infections are available. Here, we present the noninvasive pathogen-specific detection of using novel fluorescent probes that target the bacterial biofilm-associated lectins LecA and LecB. Several glycomimetic probes were developed to target these extracellular lectins and demonstrated to stain biofilms . Importantly, for the targeting of LecA an activity boost to low-nanomolar affinity could be achieved, which is essential for application. , the nanomolar divalent LecA-targeted imaging probe accumulated effectively in biofilms under flow conditions, independent of the fluorophore identity. Investigation of these glycomimetic imaging probes in a murine lung infection model and fluorescence imaging revealed accumulation at the infection site. These findings demonstrate the use of LecA- and LecB-targeting probes for the imaging of infections and suggest their potential as pathogen-specific diagnostics to accelerate the start of the appropriate treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11672137PMC
http://dx.doi.org/10.1021/jacsau.4c00670DOI Listing

Publication Analysis

Top Keywords

high-affinity lectin
4
lectin ligands
4
ligands enable
4
enable detection
4
detection pathogenic
4
pathogenic biofilms
4
biofilms implications
4
implications diagnostics
4
diagnostics therapy
4
therapy critical
4

Similar Publications

The dynamic interaction between immune recognition molecules and signaling pathways in the innate immune response of Penaeus monodon to White Spot Syndrome Virus (WSSV) infection is unveiled in this study. Through comprehensive gene expression profiling, we demonstrate significant upregulation of key immune genes, including a specific C-type lectin and a defined ficolin isoform, in WSSV-infected hemocytes, underscoring their pivotal roles in pathogen recognition and antiviral defense. Leveraging advanced molecular techniques, we successfully expressed, purified, and characterized these recombinant proteins, revealing their time-dependent expression and high-affinity binding to lipopolysaccharides (LPS).

View Article and Find Full Text PDF

Ricin, a ribosome-inactivating lectin from seeds, has been used as a bioterrorism agent in multiple cases. While passive immunotherapy with anti-ricin antibodies shows promise in preclinical studies, no approved countermeasure exists. Developing effective monoclonal antibodies (mAbs) is challenging, requiring epitope targeting that ensures neutralization of the two most dominant natural ricin isoforms (D and E).

View Article and Find Full Text PDF

Acute myeloid leukemia (AML), a hematologic malignancy, is an important public health issue. It is a result of the abnormal proliferation of immature myeloid cells. Despite advancements in diagnostic procedures, the early identification of AML remains a significant clinical challenge, marking a distinctive niche for newer theranostic approaches to ameliorate diagnosis and treatment.

View Article and Find Full Text PDF

Unlabelled: Bacterial adhesins such as FimH are critical for host colonization and persistence under the mechanical forces encountered at sites of infection such as the urinary tract. Despite decades of research, the molecular mechanisms by which FimH-a key virulence factor of -regulates its binding through conformational switching remain incompletely understood. FimH operates across a range of conformations that includes low- (LAS), intermediate-, high-affinity (HAS) states-- and forms catch bonds which paradoxically strengthen under force.

View Article and Find Full Text PDF

Despite advances in antibody-based therapies for leukemia, significant limitations persist, including immunogenicity, toxicity, and resistance development. To address these challenges, we pursued an innovative peptide-based targeting strategy against CD33, a well-validated surface marker in leukemia. This study establishes a comprehensive pipeline integrating computational design with experimental validation to develop novel CD33-targeting peptides with optimal therapeutic properties.

View Article and Find Full Text PDF